ArticleOncoTargets and therapy2021

Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study.

Jun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.